Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer

Código QR

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer

Guardado en:

Detalles Bibliográficos
Autores principales:	Huicheng Liu, Lili Bai, Liu Huang, Na Ning, Yijia Li, Xuejiao Dong, Qiuyang Du, Minghui Xia, Yufei Chen, Likun Zhao, Yanhu Li, Qingwu Meng, Yaqi Duan, Jie Ming, Andy Qingan Yuan, Xiang-Ping Yang
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/496da0e943304287b5b4e49e748a142e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
por: Sara Bravaccini, et al.
Publicado: (2021)

Une affaire trop sérieuse ?
por: Seppo Hentilä
Publicado: (2002)

Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
por: Fatih M. Uckun, et al.
Publicado: (2021)

Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study.
por: Isabella Morais Martins Barros, et al.
Publicado: (2021)

Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study
por: Isabella Morais Martins Barros, et al.
Publicado: (2021)

Development of selective bispecific Wnt mimetics for bone loss and repair
por: Tristan W. Fowler, et al.
Publicado: (2021)

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
por: Pan H, et al.
Publicado: (2018)

Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
por: Aleksandra Rodak, et al.
Publicado: (2021)

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Martin A. Redhead, et al.
Publicado: (2021)

Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics
por: Karen Froning, et al.
Publicado: (2020)

Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Publicado: (2021)

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
por: Monica Florio, et al.
Publicado: (2016)

A new approach to produce IgG4-like bispecific antibodies
por: Caizhi Zhao, et al.
Publicado: (2021)

T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
por: Daisuke Kamakura, et al.
Publicado: (2021)

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Barbara Savoldo, et al.
Publicado: (2021)

Single-Cell Proteomic Profiling Identifies Nanoparticle Enhanced Therapy for Triple Negative Breast Cancer Stem Cells
por: Wenzheng Wang, et al.
Publicado: (2021)

Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
por: Tianchuan Zhu, et al.
Publicado: (2021)

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
por: Wen-Wei Lin, et al.
Publicado: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman ML, et al.
Publicado: (2015)

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance
por: Lu Shan, et al.
Publicado: (2021)

Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Martin A. Redhead, et al.
Publicado: (2021)

Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
por: Aran F. Labrijn, et al.
Publicado: (2017)

A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity
por: Aruto Sugiyama, et al.
Publicado: (2017)

Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
por: Hong-fen Guo, et al.
Publicado: (2021)

A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
por: Xiaopei Cui, et al.
Publicado: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Wenjie Zhao, et al.
Publicado: (2021)

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Fangfang Duan, et al.
Publicado: (2021)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Daxing Liu, et al.
Publicado: (2018)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
por: Ye J, et al.
Publicado: (2016)

Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies
por: Christina L. Parker, et al.
Publicado: (2020)

A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells
por: Jonathan W. Cruz, et al.
Publicado: (2019)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012)

Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein
por: Chen H, et al.
Publicado: (2018)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
por: Yubao Zhang, et al.
Publicado: (2021)

Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices
por: Stefan Dengl, et al.
Publicado: (2020)

Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system
por: Lei Han, et al.
Publicado: (2017)

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
por: Eugenia Zah, et al.
Publicado: (2020)